中华神经科杂志2024,Vol.57Issue(4) :315-325.DOI:10.3760/cma.j.cn113694-20230906-00124

中国遗传性共济失调诊治专家共识2024

Chinese expert consensus on the diagnosis and treatment of hereditary ataxia 2024

中华医学会神经病学分会神经遗传学组 江泓 吴志英
中华神经科杂志2024,Vol.57Issue(4) :315-325.DOI:10.3760/cma.j.cn113694-20230906-00124

中国遗传性共济失调诊治专家共识2024

Chinese expert consensus on the diagnosis and treatment of hereditary ataxia 2024

中华医学会神经病学分会神经遗传学组 江泓 1吴志英2
扫码查看

作者信息

  • 1. 中南大学湘雅医院神经内科,长沙410008
  • 2. 浙江大学医学院附属第二医院医学遗传科,罕见病诊治中心,杭州 310009
  • 折叠

摘要

遗传性共济失调(HA)是一大类具有高度临床和遗传异质性的神经遗传性疾病.为提高临床医师对HA的认识及诊治水平,我国HA诊治领域的专家在2015版《遗传性共济失调诊断与治疗专家共识》的基础上进行了更新和完善,并在中华医学会神经病学分会神经遗传学组会议上反复讨论修改后定稿,进一步制订了此共识.共识内容包括HA的分子分型、临床表现、辅助检查、诊断、鉴别诊断、治疗及遗传咨询等.

Abstract

Hereditary ataxia(HA)is a group of neurogenetic diseases with high clinical and genetic heterogeneity In order to improve the understanding of this disease,experts in the field of HA in China have improved and revised the 2015 version of the"Expert consensus on the diagnosis and treatment of genetic ataxia"and developed this consensus.The revised consensus has been repeatedly discussed and finalized at meetings of Chinese Society of Neurogenetics.This consensus includes molecular genetics,clinical manifestations,diagnostic tests,diagnosis and differential diagnosis,treatment,and genetic counseling of HA.

关键词

遗传性共济失调/诊断/治疗/专家共识

Key words

Hereditary ataxia/Diagnosis/Treatment/Consensus

引用本文复制引用

出版年

2024
中华神经科杂志
中华医学会

中华神经科杂志

CSTPCD北大核心
影响因子:1.329
ISSN:1006-7876
参考文献量86
段落导航相关论文